About Cogent Biosciences
Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM...
Open Jobs at Cogent Biosciences (17)
- Cogent Biosciences · Remote, United States · 8d$180k – $210k
- Cogent Biosciences · Remote, United States · 9d$150k – $190k
- Cogent Biosciences · Waltham, Massachusetts, United… · 10d$200k – $230k
- Cogent Biosciences · Remote, United States · 11d$210k – $240k
- Cogent Biosciences · Remote, United States · 16d$205k – $240k
- Cogent Biosciences · Remote, United States · 17d$155k – $185k
- Cogent Biosciences · Waltham, Massachusetts, United… · 17d$185k – $215k
- Cogent Biosciences · Waltham, Massachusetts, United… · 21d$180k
- Cogent Biosciences · Remote, United States · 22d$180k – $205k
- Cogent Biosciences · Remote, United States · 22d$320k
- Cogent Biosciences · Waltham, Massachusetts, United… · 25d$195k – $230k
- Cogent Biosciences · Boulder, Colorado, United Stat… · 1mo
- Cogent Biosciences · Boulder, Colorado, United Stat… · 1mo$180k – $210k
- Cogent Biosciences · Waltham, Massachusetts, United… · 2mo$73k – $87k
- Cogent Biosciences · Waltham, Massachusetts, United… · 2mo$225k – $265k
- Cogent Biosciences · Remote, United States · 3mo$240k – $280k
- Cogent Biosciences · Remote, United States · 5mo$205k – $240k